Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Sees Pegasys Approval Delay Until 2002, But With Broader Indication

Aug 20 2001

• By The Pink Sheet

Related Content

Roche Sees Global Regulatory "Tightening," Not FDA "Slowdown"

Aug 20 2001

Schering PEG-Intron/Rebetol Phase IV To Evaluate Alternate Dosing Regimen

Aug 20 2001

Accutane Psychiatric Safety Trial Planned: Roche Prepares For Hearings

Aug 20 2001

Roche Xenical Patient Retention Program Is Key To Sales Growth

Mar 05 2001

Schering PEG-Intron Phase IV Trial To Study African Americans

Jan 29 2001

Roche Pegasys

Apr 30 2001

Roche Agenda For 2001 Includes Kytril NDA For Post-Op Use, Pegasys Launch

Mar 19 2001

Roche Pares Back To Specialty Care: U.S. Sales Force Will Be Cut By 24%

Jun 04 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window